Enfoques contemporáneos en el tratamiento de la estenosis aórtica

##plugins.themes.bootstrap3.article.sidebar##

PDF (Português (Brasil))
Publicado Jul 23, 2023
DOI https://doi.org/10.25248/reamed.e13372.2023

##plugins.themes.bootstrap3.article.main##

Anderson Medeiros Filho
Universidade de Vassouras
Amanda de Moura Cordeiro
Fernanda Pereira Paixão Silva
Jessica de Paula Chalup Junqueira
Larissa do Nascimento Souza
Nayara Toledo da Silva Abreu
Patricia Mascarenhas de Santana
Pedro Henrique Braga Bastos Goulart de Azevedo
Telma Storti Nóbrega
Mario Luiz Jacobino Ribeiro

Resumen

Objetivo: Revisar la evidencia disponible sobre los enfoques para la estenosis aórtica, incluido el reemplazo valvular aórtico transcatéter y la cirugía valvular aórtica mínimamente invasiva. Métodos: Este es un estudio de revisión integradora. Las bases de datos utilizadas fueron PubMed y BVS. La búsqueda de artículos se realizó considerando los descriptores “Reemplazo valvular aórtico transcatéter”, “Estenosis valvular aórtica” y “Procedimientos quirúrgicos cardiovasculares”, utilizando el operador booleano “AND”. Se incluyeron artículos publicados entre 2022-2023; en ingles; acceso libre; estudio clínico, ensayo clínico, estudio observacional y ensayo clínico controlado. Resultados: De los artículos analizados, veinte abordaron los beneficios y resultados positivos de TAVR. Estos estudios destacaron tasas de mortalidad reducidas, buenos resultados a corto y largo plazo y TAVR como una opción rentable. Por otro lado, nueve artículos discutieron las complicaciones y desafíos asociados con TAVI. Problemas como el desajuste prótesis-paciente, anomalías de la conducción, lesión renal aguda y trastornos de la coagulación. Además, tres artículos reportaron un beneficio significativo al usar cirugía convencional en pacientes obesos y pacientes con disfunción ventricular izquierda. Consideraciones finales: TAVR es seguro y eficaz, con una baja tasa de mortalidad. Por otro lado, MIARV tiene como objetivo preservar y reparar la válvula nativa, ofreciendo un menor riesgo de complicaciones.

##plugins.themes.bootstrap3.article.details##

Cómo citar
Medeiros FilhoA., CordeiroA. de M., SilvaF. P. P., JunqueiraJ. de P. C., SouzaL. do N., AbreuN. T. da S., SantanaP. M. de, AzevedoP. H. B. B. G. de, NóbregaT. S., & RibeiroM. L. J. (2023). Enfoques contemporáneos en el tratamiento de la estenosis aórtica. Revista Eletrônica Acervo Médico, 23(7), e13372. https://doi.org/10.25248/reamed.e13372.2023
Número
Vol. 23 Núm. 7 (2023): Revista Eletrônica Acervo Médico (ISSN 2764-0485) | Volume 23 (7) | 2023
Sección
Revisão Bibliográfica

Copyright © | Todos los derechos reservados.

La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.

Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.

Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.

Citas

1. AIDIETIS A, et al. 30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve: The Hydra CE Study. JACC Cardiovasc Interv, 2022; 15(1): 93–104.

2. ALASNAG M, et al. One-Year Outcomes for Patients Undergoing Transcatheter Aortic Valve Replacement: The Gulf TAVR Registry. Cardiovasc Revasc Med, 2022; 41: 19–26.

3. BAUMGARTNER H, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 2017; 38(36): 2739–2791.

4. CHEN CG, et al. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Low-risk Patients: A Meta-Analysis Based on a 2-Year Follow-Up. Anatol J Cardiol, 2022; 26(11): 802–809.

5. DISMORR M, et al. Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement. Journal of the American College of Cardiology, 2023; 81(10): 964–975.

6. ESPOSITO G, et al. Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves. Open Heart, 2022; 9(2): e001995.

7. HARADA M, et al. Changes in platelet function and coagulation after transcatheter aortic valve implantation evaluated with thromboelastography. Open Heart, 2022; 9(2): e002132.

8. HUCZEK Z, et al. Transcatheter aortic valve­in­valve implantation for failed surgical bioprostheses: results from the Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV­TAVI) Registry. Pol. Arch. Med. Wew. (Online), 2022; 132(2).

9. JALAVA MP, et al. Transcatheter and surgical aortic valve replacement in patients with left ventricular dysfunction. Journal of Cardiothoracic Surgery, 2022; 17(1): 322.

10. KANG SL, et al. Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation? Catheter Cardiovasc Interv, 2022; 99(4): 1138–1148.

11. KORCZAK A, et al. Acute kidney injury as the most important predictor of poor prognosis after interventional treatment for aortic stenosis. Kardiol Pol, 2022; 80(10): 1032–1038.

12. KUCK KH, et al. Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk. Adv Ther, 2023; 40(3): 1031–1046.

13. LANGE T, et al. Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance, 2022; 24(1): 45.

14. MAGRO PL e SOUSA-UVA M. In low-risk patients aged >70-75 with severe aortic stenosis, is transcatheter superior to surgical aortic valve replacement in terms of reported cardiovascular composite outcomes and survival? Interact Cardiovasc Thorac Surg, 2022; 34(1): 40–44.

15. MAILEY JA, et al. Reframing Optimal Implantation of the Sapien 3 Transcatheter Heart Valve. The Journal of Invasive Cardiology, 2022; 34(5): 380–389.

16. MAJMUNDAR M, et al. Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis. EuroIntervention, 2022; 8(1): 23–32.

17. MCINERNEY A, et al. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis. EuroIntervention, 2022; 18(5): 417–427.

18. MEDRANDA GA, et al. Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022; 18(5): 407–416.

19. MUNERETTO C, et al. Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study. J Thorac Cardiovasc Surg, 2022; 163(3): 925- 935.

20. NARDI G, et al. Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022; 17(17): 1397–1406.

21. OKUNO T, et al. Transcatheter aortic valve implantation in patients with rheumatic aortic stenosis. Heart, 2022; 108(15): 1225–1233.

22. OLIEMY A e AL-ATTAR N. Transcatheter aortic valve implantation. F1000Prime Reports, 2014; 6: 92.

23. PEREIRA AS, et al. Metodologia da pesquisa científica. [s.l.] Brasil, 2018.

24. RAM E, et al. Frailty and clinical outcomes following aortic valve replacement. Journal of Cardiac Surgery, 2022; 37(10): 3036–3043.

25. RIZIK DG, et al. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial. JAMA network open, 2022; 5(10): e2238792.

26. ROBERTSON DM, et al. Transcatheter and Surgical Aortic Valve Implantation in Children, Adolescents, and Young Adults With Congenital Heart Disease. Am J Cardiol, 2022; 177: 128–136.

27. SÁ MP, et al. Late Outcomes After Aortic Root Enlargement During Aortic Valve Replacement: Meta-Analysis With Reconstructed Time-To-Event Data. J Cardiothorac Vasc Anesth, 2022; 36(8): 3065–3073.

28. SIQUEIRA DAA, et al. Single-center experience with merils myval transcatheter heart valve. J. Transcatheter Interv, 2022; 30(1): 100–101.

29. TARASOUTCHI F, et al. Atualização das Diretrizes Brasileiras de Valvopatias – 2020. Arquivos Brasileiros de Cardiologia, 2020; 115(4): 720–775.

30. THADEN JJ, et al. Sex-related differences in calcific aortic stenosis: correlating clinical and echocardiographic characteristics and computed tomography aortic valve calcium score to excised aortic valve weight. European Heart Journal, 2016; 37(8): 693–699.

31. TOMALA O, et al. Comparison of outcomes of trans-subclavian versus trans-apical approaches in transcatheter aortic valve implantation. Journal of Cardiothoracic Surgery, 2022; 17(1): 180.

32. TOMII D, et al. Long-term outcomes of new-onset conduction abnormalities following transcatheter aortic valve implantation. Archives of Cardiovascular Diseases, 2022; 115(4): 214–224.

33. TOMII D, et al. Impact of First-Phase Ejection Fraction on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation. Cardiovascular Revascularization Medicine: Including Molecular Interventions, 2022; 42: 55–61.

34. INVESTIGATORS UTT, et al. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. JAMA, 2022; 327(19): 1875–1887.

35. WILLIAMS MR, et al. The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. JACC Cardiovasc Interv, 2022; 15(5): 523–532.